Patrick Trucchio analyst HC WAINWRIGHT

Currently out of the existing stock ratings of Patrick Trucchio, 122 are a BUY (93.85%), 5 are a SELL (3.85%), 3 are a HOLD (2.31%).

Patrick Trucchio

Work Performance Price Targets & Ratings Chart

Analyst Patrick Trucchio works at HC WAINWRIGHT with a stock forecast success ratio of 20.57% fulfilled within 34.93 days on average. Previously, Patrick Trucchio worked at BERENBERG.

Patrick Trucchio’s has documented 235 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MIST, Milestone Pharmaceuticals at 26-Feb-2024.

Wall Street Analyst Patrick Trucchio

Analyst best performing recommendations are on MNMD (MIND MEDICINE ).
The best stock recommendation documented was for MNMD (MIND MEDICINE ) at 9/21/2022. The price target of $5 was fulfilled within 7 days with a profit of $1.39 (21.75%) receiving and performance score of 31.08.

Average potential price target upside

ALLK Allakos ALNY Alnylam Pharmaceuticals ATAI ATAI Life Sciences BV CMPS Compass Pathways Plc FLXN Flexion Therapeutics MNK Mallinckrodt plc CYBN Cybin  FSTX FStar Therapeutics FTRP Field Trip Health Ltd MNMD Mind Medicine  VIR Vir Biotechnology ALT Altimmune ARWR Arrowhead Pharmaceuticals ARNA Arena Pharmaceuticals BNTC Benitec Biopharma Ltd ADR DMTTF Small Pharma FIXX Homology Medicines FRLN Freeline Therapeutics Holdings Plc GHRS GH Research PLC IMCR Immunocore Holdings Ltd LBPH Longboard Pharmaceuticals MIST Milestone Pharmaceuticals MSSTF Mindset Pharma PRGO Perrigo Company PLC SLN Silence Therapeutics PLC DTIL Precision BioSciences GOSS Gossamer Bio IVVD Invivyd . ONCY Oncolytics Biotech QURE Uniqure NV SGMO Sangamo Therapeutics

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$-0.46 (-31.51%)


1 months 11 days ago

4/6 (66.67%)

$-1.99 (-66.56%)




$0.04 (2.74%)


1 months 11 days ago

3/4 (75%)

$-1.49 (-49.83%)




$1.54 (105.48%)

1 months 11 days ago

0/2 (0%)

$0.01 (0.33%)


2 months 10 days ago

1/1 (100%)

$32.69 (83.16%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Patrick Trucchio is most bullish on?

Potential upside of $236.34 has been obtained for ALNY (ALNYLAM PHARMACEUTICALS)

Which stock is Patrick Trucchio is most reserved on?

Potential downside of -$13.04 has been obtained for DTIL (PRECISION BIOSCIENCES)

What Year was the first public recommendation made by Patrick Trucchio?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?